Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert H Knopp

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
The American Journal of Cardiology|June 27, 2002
Risk factors for coronary artery disease in womenRobert H Knopp
Current Opinion in Lipidology|July 10, 2004
Estrogens, lipoproteins, and cardiovascular risk factors: an update following the randomized placebo-controlled trials of hormone-replacement therapyMary Seed, Robert H Knopp
Metabolic Syndrome and Related Disorders|March 29, 2008
Metabolic syndrome in women of childbearing age and pregnancy: recognition and management of dyslipidemiaPathmaja Paramsothy, Robert H Knopp
Current Cardiology Reports|October 16, 2003
Estrogen therapies, lipids, and the heart disease prevention controversyRobert H Knopp, Keiko Aikawa, Eleanor A Knopp
Diabetes Care|September 28, 2002
Gestational diabetes and the incidence of type 2 diabetes: a systematic reviewCatherine Kim, Katherine M Newton, Robert H Knopp
The American Journal of Cardiology|June 14, 2008
Comprehensive lipid management versus aggressive low-density lipoprotein lowering to reduce cardiovascular riskRobert H Knopp, Pathmaja Paramsothy, Benjamin Atkinson, et al.
The American Journal of Cardiology|April 8, 2003
Management of patients with diabetic hyperlipidemiaRobert H Knopp, Barbara Retzlaff, Keiko Aikawa, et al.
Diabetes Care|June 28, 2006
Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)Robert H Knopp, Michael d'Emden, Johan G Smilde, et al.
Family Medicine|November 9, 2004
Physician informational needs in providing nutritional guidance to patientsTanis V Mihalynuk, Robert H Knopp, Craig S Scott, et al.
Experimental Biology and Medicine (Maywood, N.J.)|November 4, 2004
Low-density lipoprotein inhibits secretion of phospholipid transfer protein in human trophoblastic BeWo cellsAn-Yue Tu, Marian C Cheung, Xiaodong Zhu, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
The American Journal of Cardiology|June 27, 2002
Risk factors for coronary artery disease in womenRobert H Knopp
Current Opinion in Lipidology|July 10, 2004
Estrogens, lipoproteins, and cardiovascular risk factors: an update following the randomized placebo-controlled trials of hormone-replacement therapyMary Seed, Robert H Knopp
Metabolic Syndrome and Related Disorders|March 29, 2008
Metabolic syndrome in women of childbearing age and pregnancy: recognition and management of dyslipidemiaPathmaja Paramsothy, Robert H Knopp
Current Cardiology Reports|October 16, 2003
Estrogen therapies, lipids, and the heart disease prevention controversyRobert H Knopp, Keiko Aikawa, Eleanor A Knopp
Diabetes Care|September 28, 2002
Gestational diabetes and the incidence of type 2 diabetes: a systematic reviewCatherine Kim, Katherine M Newton, Robert H Knopp
The American Journal of Cardiology|June 14, 2008
Comprehensive lipid management versus aggressive low-density lipoprotein lowering to reduce cardiovascular riskRobert H Knopp, Pathmaja Paramsothy, Benjamin Atkinson, et al.
The American Journal of Cardiology|April 8, 2003
Management of patients with diabetic hyperlipidemiaRobert H Knopp, Barbara Retzlaff, Keiko Aikawa, et al.
Diabetes Care|June 28, 2006
Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)Robert H Knopp, Michael d'Emden, Johan G Smilde, et al.
Family Medicine|November 9, 2004
Physician informational needs in providing nutritional guidance to patientsTanis V Mihalynuk, Robert H Knopp, Craig S Scott, et al.
Experimental Biology and Medicine (Maywood, N.J.)|November 4, 2004
Low-density lipoprotein inhibits secretion of phospholipid transfer protein in human trophoblastic BeWo cellsAn-Yue Tu, Marian C Cheung, Xiaodong Zhu, et al.
Pageof 5